/
Slow-release Slow-release

Slow-release - PowerPoint Presentation

celsa-spraggs
celsa-spraggs . @celsa-spraggs
Follow
387 views
Uploaded On 2016-04-22

Slow-release - PPT Presentation

ivermectin formulations for malaria vector control Current status and prospects Carlos Chaccour MD MSc Does IVM kill gambiae Direct feedings 24 hours after 200mcgkg ID: 288745

ivm release hours membrane release ivm membrane hours window slow transmission vitro mixing 2010 gambiae kobylinski chaccour prospects weeks

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Slow-release" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Slow-release ivermectin formulations for malaria vector control

Current

status and prospects

Carlos Chaccour MD MScSlide2

Does IVM kill gambiae?Direct feedings

24 hours after 200mcg/kgJID 2010Slide3

How much IVM kills gambiae?The minimum insecticidal concentration22.4 ng/ml (18-27 ng/ml) Kobylinski 2010In vitro mixing + membrane16 ng

/ml (14-17 ng/ml) Kobylinski 2012In vitro mixing + membrane6 ng

/ml (4-7 ng/ml) Bousema 2013Volunteers + membraneSlide4

MIC + PK = The mosquitocidal windowSlide5

22

ng/ml

18 hoursSlide6

6

ng

/ml40 hoursSlide7

Why is this important?A key factor for interrupting transmission would be the time IVM remains in blood above mosquito-killing levels (i.e the width of the window)(Slater et al 2014)Slide8

Widening the windowIncrease a single dose (mcg/kg)i.e. Higher CmaxIntermitent treatment i.e. Consecutive peaksSlow release

----> Alter the curve (!)Oral (bowel transit time)Parenteral Slide9

First attempt…Maeda 2003Cunnigham 2006Slide10

3 formulations: F – M - XI – II – III per subjectCuantificationsWeekly (12 weeks)Monthly (12-24 weeks)Extensive toxicology studySlide11
Slide12
Slide13

Stable concentrations can be safely achieved modifying the formulationSlow release technology available todayThe modelled impact

on transmission is very promisingSlide14

Prospects, gaps and messageNew slow release formulationsSlow release pillTransdermal patchesPill + patch approachPegilated subcutaneous

Knowledge gapsJoint work on TPPSlide15

Juliane Chaccour.Ángel Irigoyen, Ana G. Gil, Felix Hammann, Jose L Del Pozo.The MISSION Team: Santi, Chema, Rocio, Isa, Alberto.Campaign supporters and donnors